Scarica l'app Stockscreener
9.55
0.21%
0.02
Dopo l'orario di chiusura:
9.55
Precedente Chiudi:
$9.53
Aprire:
$9.55
Volume 24 ore:
447.61K
Relative Volume:
0.55
Capitalizzazione di mercato:
$730.09M
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-3.3045
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
+0.21%
1M Prestazione:
-17.10%
6M Prestazione:
-36.33%
1 anno Prestazione:
-61.16%
Intervallo 1D:
$9.51
$9.72
Intervallo di 1 settimana:
$9.28
$10.33
Portata 52W:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Nome
Nurix Therapeutics Inc
Settore
Industria
Telefono
(415) 660-5320
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Confronta NRIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.55 | 728.56M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | Leerink Partners | Market Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | Jefferies | Buy |
| 2024-09-06 | Ripresa | Robert W. Baird | Outperform |
| 2024-07-31 | Iniziato | Truist | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-09 | Iniziato | Barclays | Overweight |
| 2023-02-28 | Iniziato | Oppenheimer | Outperform |
| 2022-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-12-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-30 | Ripresa | Piper Sandler | Overweight |
| 2021-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2020-11-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Stifel | Buy |
Mostra tutto
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Candriam S.C.A. Sells 45,695 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics, Inc. $NRIX Shares Sold by Wellington Management Group LLP - MarketBeat
What institutional flow reveals about Nurix Therapeutics Inc.2025 Top Gainers & Daily Price Action Insights - Newser
Will breakout in Nurix Therapeutics Inc. lead to full recoveryWatch List & Fast Gaining Stock Strategy Reports - Newser
Is Nurix Therapeutics Inc. stock reversal real or fakeJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Market reaction to Nurix Therapeutics Inc.’s recent newsMarket Growth Summary & Stock Portfolio Risk Control - Newser
Using fundamentals and technicals on Nurix Therapeutics Inc.July 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
What high frequency data says about Nurix Therapeutics Inc.July 2025 Selloffs & Low Volatility Stock Recommendations - Newser
Combining price and volume data for Nurix Therapeutics Inc.2025 Trading Recap & Daily Stock Trend Reports - Newser
Volatility clustering patterns for Nurix Therapeutics Inc.2025 Dividend Review & Risk Controlled Daily Trade Plans - Newser
Visual analytics tools that track Nurix Therapeutics Inc. performance2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
What to do if you’re stuck in Nurix Therapeutics Inc.July 2025 Drop Watch & Long-Term Safe Return Strategies - Newser
What technical models suggest about Nurix Therapeutics Inc.’s comebackJuly 2025 Action & Smart Swing Trading Techniques - Newser
Analyzing net buyer seller activity in Nurix Therapeutics Inc.Weekly Trade Analysis & Real-Time Sentiment Analysis - Newser
Nurix Therapeutics, Inc. $NRIX Shares Acquired by T. Rowe Price Investment Management Inc. - MarketBeat
Analyzing Nurix Therapeutics Inc. with multi timeframe chartsJuly 2025 Patterns & Fast Gain Stock Trading Tips - Newser
Brokerages Set Nurix Therapeutics, Inc. (NASDAQ:NRIX) Target Price at $28.87 - MarketBeat
A | Why is Nurix Therapeutics, Inc. stock going downDollar Strength & Real-Time Stock Movement Alerts - theviewers.co.kr
Is Nurix Therapeutics Inc. stock poised for growth2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Trend analysis for Nurix Therapeutics Inc. this weekBear Alert & Fast Moving Stock Trade Plans - Newser
Tools to assess Nurix Therapeutics Inc.’s risk profileJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser
Real time scanner hits for Nurix Therapeutics Inc. explainedWeekly Trend Recap & Technical Pattern Based Signals - Newser
Nurix Therapeutics Inc. Stock Support and Resistance Levels You Should Know2025 Performance Recap & Community Verified Watchlist Alerts - Newser
Strategies to average down on Nurix Therapeutics Inc.Weekly Trend Summary & Verified Momentum Stock Ideas - Newser
What machine learning models say about Nurix Therapeutics Inc.2025 Top Decliners & Weekly High Potential Stock Alerts - Newser
Nurix Therapeutics Announces Leadership Change in Committee - The Globe and Mail
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 4.4%Should You Sell? - MarketBeat
Nurix Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Can a trend reversal in Nurix Therapeutics Inc. lead to recoveryEarnings Performance Report & Risk Managed Trade Strategies - Newser
Nurix Therapeutics, Inc. $NRIX Stock Holdings Decreased by Deutsche Bank AG - MarketBeat
Does Nurix Therapeutics Inc. have declining or rising EPSJuly 2025 Volume & Short-Term Trading Alerts - theviewers.co.kr
Automated trading signals detected on Nurix Therapeutics Inc.Weekly Loss Report & Accurate Intraday Trading Signals - Newser
Nurix Therapeutics Inc. stock retracement – recovery analysisMarket Performance Recap & Risk Controlled Stock Alerts - Newser
Is Nurix Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideEarnings Growth Report & Community Verified Swing Trade Signals - Newser
Nurix Therapeutics (NASDAQ:NRIX) Trading 7.7% HigherWhat's Next? - MarketBeat
Will Volume Confirm Reversal in Nurix Therapeutics Inc.July 2025 Intraday Action & High Accuracy Swing Trade Signals - newsimpact.co.kr
How to escape a deep drawdown in Nurix Therapeutics Inc.Market Trend Report & Weekly Top Stock Performers List - Newser
Technical Bounce Expected in Nurix Therapeutics Inc. Next Week2025 Institutional Moves & Comprehensive Market Scan Reports - metal.it
Is Nurix Therapeutics Inc. trending in predictive chart modelsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):